Riskpilot← Back to searchSign inGet full accessPHARMA TECHNOLOGY A/S
A/SActiveCVR 20826746Åshøjvej 24Engineering activities and related technical consultancy · NACE 7112Est. 199833 employees
Revenue 2024
DKK 34,7M
+23% vs 2023
EBITDA margin
33.7%
-10% vs 2023
Equity ratio
36.4%
Financial strength
Net profit 2024
DKK 9M
-10% vs 2023
| Revenue | DKK 34,7M | +23% |
| EBITDA | DKK 11,7M | -10% |
| Net profit | DKK 9M | -10% |
| Total assets | DKK 26,2M | +9% |
| Equity | DKK 9,5M | -10% |
| Employees | 33 | — |
Legal name
PHARMA TECHNOLOGY A/S
CVR number
20826746
Legal form
Aktieselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
31. marts 1998
Share capital
DKK 500.000
Employees
33 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening, hvoraf den ene skal være formand, eller af en direktør.
Company purpose
Selskabets formål er: at udføre konsulentassistance m.v.
Address
Åshøjvej 24
Phone
+4556638080
Email
pharma.technology.ihh@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.987 | 12.826 | 24.462 | 10.572 | 18.519 | 16.234 | 10.930 | 9.323 | 13.926 | 19.151 | 20.334 | 28.277 | 34.739 |
| Staff expenses | -4.102 | -8.033 | -8.715 | -5.678 | -11.423 | -9.408 | -6.387 | -4.528 | -5.800 | -9.226 | -11.055 | -15.219 | -23.040 |
| EBITDA | 1.885 | 4.793 | 6.046 | 4.893 | 7.096 | 6.826 | 4.543 | 4.795 | 8.126 | 9.925 | 9.279 | 13.058 | 11.699 |
| Depreciation & amort. | 29 | 30 | -30 | -30 | -16 | -0 | -0 | -0 | -27 | -117 | -140 | -140 | -140 |
| EBIT | 1.855 | 4.763 | 6.016 | 4.864 | 7.080 | 6.826 | 4.543 | 4.795 | 8.100 | 9.808 | 9.139 | 12.917 | 11.558 |
| Net financials | 52 | 53 | 45 | 2 | -1 | -5 | -9 | -14 | -21 | -37 | -35 | -8 | 40 |
| Profit before tax | 1.907 | 4.816 | 6.061 | 4.865 | 7.079 | 6.821 | 4.534 | 4.781 | 8.079 | 9.771 | 9.104 | 12.910 | 11.599 |
| Tax | 478 | 1.249 | 1.493 | 1.144 | 1.561 | 1.501 | 998 | 1.052 | 1.777 | 2.150 | 2.003 | 2.840 | 2.552 |
| Net profit | 1.429 | 3.567 | 4.568 | 3.722 | 5.519 | 5.320 | 3.537 | 3.729 | 6.301 | 7.621 | 7.101 | 10.070 | 9.047 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.090 | 10.593 | 9.292 | 7.915 | 12.985 | 10.111 | 8.103 | 13.486 | 18.925 | 18.717 | 20.962 | 23.996 | 26.230 |
| Equity | 1.929 | 4.067 | 5.068 | 4.789 | 6.586 | 5.820 | 4.037 | 4.229 | 6.801 | 8.121 | 7.601 | 10.570 | 9.547 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 248 | 248 | 0 | 0 | 0 |
| Short-term debt | 3.159 | 6.527 | 4.225 | 3.126 | 6.399 | 4.291 | 4.067 | 9.222 | 11.862 | 10.327 | 13.346 | 13.422 | 16.683 |
| Total debt | 3.159 | 6.527 | 4.225 | 3.126 | 6.399 | 4.291 | 4.067 | 9.257 | 12.110 | 10.574 | 13.346 | 13.422 | 16.683 |
EBITDA margin
33.7%
This company
15.8%
Market median
+113% vs market
20122024
Equity ratio
36.4%
This company
38.2%
Market median
+5% vs market
20122024
Return on equity
94.8%
This company
18.4%
Market median
+415% vs market
20122024
Net profit margin
26.0%
This company
8.1%
Market median
+221% vs market
20122024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20122024
Debt / equity
1.75×
This company
0.62×
Market median
-182% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AW Founder | Founder | 1998 | — | — |
FS Management | Management | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2003 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1998 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FPIH HOLDING ApS | Company | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FPIH HOLDING ApS
PHARMA TECHNOLOGY A/S Board members of PHARMA TECHNOLOGY A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Allan Weimar Andersen | Founder | 0 companies |
| Flemming Sten Pedersen | Management | 0 companies |
| Bjarne Grølsted-Kristensen | Board of Directors | 0 companies |
| Claus Løndal Nielsen | Board of Directors | 0 companies |
| Inge Holsted Hansen | Board of Directors | 0 companies |
| Svenn Ryberg Hansen | Board of Directors | 0 companies |